Trademark: 97975831
Word
WUXI XDC THE BIOCONJUGATION LEADER
Status Date
Tuesday, July 18, 2023
Registration Number
7116996
Registration Date
Tuesday, July 18, 2023
Filing Date
Saturday, September 18, 2021
Published for Opposition
Tuesday, September 13, 2022
40 Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
42 Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates
The mark consists of the stylized wordings "WUXI" over "XDC", partially inside an incomplete oval outline that intersects with another incomplete oval outline. Below these appears the wording "THE BIOCONJUGATION LEADER" in stylized font.
"WUXI" OR "BIOCONJUGATION"
Jul 18, 2023
Notice Of Registration Confirmation Emailed
Jul 18, 2023
Registered-Principal Register
Jun 16, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 15, 2023
Electronic Record Review Complete
Jun 15, 2023
Electronic Record Review Complete
Jun 9, 2023
On Hold - Electronic Record Review Required
Jun 9, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 8, 2023
Allowed Principal Register - Sou Accepted
Jun 2, 2023
Notice Of Design Search Code E-Mailed
Jun 1, 2023
Statement Of Use Processing Complete
May 5, 2023
Use Amendment Filed
Jun 1, 2023
Divisional Processing Complete
May 5, 2023
Divisional Request Received
May 30, 2023
Case Assigned To Intent To Use Paralegal
May 5, 2023
Teas Request To Divide Received
May 5, 2023
Teas Statement Of Use Received
Nov 8, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Aug 9, 2022
Approved For Pub - Principal Register
Jun 28, 2022
Examiner's Amendment Entered
Jun 28, 2022
Notification Of Examiners Amendment E-Mailed
Jun 28, 2022
Examiners Amendment E-Mailed
Jun 28, 2022
Examiners Amendment -Written
Jun 22, 2022
Assigned To Examiner
Oct 23, 2021
Notice Of Design Search Code E-Mailed
Oct 22, 2021
New Application Office Supplied Data Entered
Sep 22, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
